nodes	percent_of_prediction	percent_of_DWPC	metapath
Estramustine—Testosterone—Prednisolone—multiple sclerosis	0.169	1	CrCrCtD
Estramustine—ABCB1—Methylprednisolone—multiple sclerosis	0.059	0.124	CbGbCtD
Estramustine—CYP3A4—Fingolimod—multiple sclerosis	0.0549	0.115	CbGbCtD
Estramustine—ABCB1—Mitoxantrone—multiple sclerosis	0.0431	0.0901	CbGbCtD
Estramustine—ABCB1—Betamethasone—multiple sclerosis	0.0384	0.0803	CbGbCtD
Estramustine—ABCB1—Prednisolone—multiple sclerosis	0.0379	0.0793	CbGbCtD
Estramustine—ABCB1—Prednisone—multiple sclerosis	0.0358	0.0749	CbGbCtD
Estramustine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0354	0.074	CbGbCtD
Estramustine—CYP3A4—Triamcinolone—multiple sclerosis	0.0268	0.0561	CbGbCtD
Estramustine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0258	0.054	CbGbCtD
Estramustine—CYP3A4—Betamethasone—multiple sclerosis	0.023	0.0481	CbGbCtD
Estramustine—CYP3A4—Prednisolone—multiple sclerosis	0.0227	0.0475	CbGbCtD
Estramustine—ABCB1—Dexamethasone—multiple sclerosis	0.0223	0.0467	CbGbCtD
Estramustine—CYP3A4—Prednisone—multiple sclerosis	0.0214	0.0449	CbGbCtD
Estramustine—ABCB1—Methotrexate—multiple sclerosis	0.0179	0.0376	CbGbCtD
Estramustine—CYP3A4—Dexamethasone—multiple sclerosis	0.0134	0.028	CbGbCtD
Estramustine—MAP2—nerve—multiple sclerosis	0.00976	0.102	CbGeAlD
Estramustine—MAP2—MAPK Cascade—MBP—multiple sclerosis	0.00815	0.115	CbGpPWpGaD
Estramustine—MAP1A—brainstem—multiple sclerosis	0.00738	0.0774	CbGeAlD
Estramustine—MAP1A—retina—multiple sclerosis	0.00712	0.0746	CbGeAlD
Estramustine—Increased tendency to bruise—Methylprednisolone—multiple sclerosis	0.00632	0.0338	CcSEcCtD
Estramustine—MAP1A—medulla oblongata—multiple sclerosis	0.00514	0.0539	CbGeAlD
Estramustine—MAP2—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.00511	0.072	CbGpPWpGaD
Estramustine—MAP1A—midbrain—multiple sclerosis	0.0047	0.0493	CbGeAlD
Estramustine—MAP1A—spinal cord—multiple sclerosis	0.00459	0.0481	CbGeAlD
Estramustine—Myelosuppression—Cladribine—multiple sclerosis	0.00421	0.0226	CcSEcCtD
Estramustine—MAP2—brainstem—multiple sclerosis	0.00419	0.044	CbGeAlD
Estramustine—MAP2—retina—multiple sclerosis	0.00404	0.0424	CbGeAlD
Estramustine—MAP1A—nervous system—multiple sclerosis	0.00387	0.0405	CbGeAlD
Estramustine—Glucose tolerance decreased—Prednisone—multiple sclerosis	0.00386	0.0206	CcSEcCtD
Estramustine—MAP1A—central nervous system—multiple sclerosis	0.00372	0.039	CbGeAlD
Estramustine—MAP1A—cerebellum—multiple sclerosis	0.00364	0.0381	CbGeAlD
Estramustine—Myelosuppression—Azathioprine—multiple sclerosis	0.00342	0.0183	CcSEcCtD
Estramustine—Thromboembolism—Prednisolone—multiple sclerosis	0.00335	0.0179	CcSEcCtD
Estramustine—Thromboembolism—Triamcinolone—multiple sclerosis	0.00308	0.0165	CcSEcCtD
Estramustine—Thromboembolism—Methylprednisolone—multiple sclerosis	0.00307	0.0165	CcSEcCtD
Estramustine—MAP1A—brain—multiple sclerosis	0.00295	0.031	CbGeAlD
Estramustine—MAP2—medulla oblongata—multiple sclerosis	0.00292	0.0307	CbGeAlD
Estramustine—Eye pain—Fingolimod—multiple sclerosis	0.0028	0.015	CcSEcCtD
Estramustine—Thromboembolism—Dexamethasone—multiple sclerosis	0.00279	0.015	CcSEcCtD
Estramustine—Thromboembolism—Betamethasone—multiple sclerosis	0.00279	0.015	CcSEcCtD
Estramustine—Myelosuppression—Mitoxantrone—multiple sclerosis	0.00277	0.0148	CcSEcCtD
Estramustine—ESR2—brainstem—multiple sclerosis	0.00272	0.0285	CbGeAlD
Estramustine—MAP2—midbrain—multiple sclerosis	0.00267	0.028	CbGeAlD
Estramustine—MAP2—spinal cord—multiple sclerosis	0.00261	0.0273	CbGeAlD
Estramustine—Cerebrovascular accident—Fingolimod—multiple sclerosis	0.00258	0.0138	CcSEcCtD
Estramustine—MAP2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.00251	0.0354	CbGpPWpGaD
Estramustine—Thromboembolism—Prednisone—multiple sclerosis	0.00243	0.013	CcSEcCtD
Estramustine—Cardiac arrest—Fingolimod—multiple sclerosis	0.0024	0.0129	CcSEcCtD
Estramustine—Liver function test abnormal—Fingolimod—multiple sclerosis	0.00234	0.0125	CcSEcCtD
Estramustine—MAP2—nervous system—multiple sclerosis	0.0022	0.023	CbGeAlD
Estramustine—MAP2—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.00212	0.0299	CbGpPWpGaD
Estramustine—MAP2—central nervous system—multiple sclerosis	0.00211	0.0222	CbGeAlD
Estramustine—Embolism venous—Prednisolone—multiple sclerosis	0.00211	0.0113	CcSEcCtD
Estramustine—MAP2—cerebellum—multiple sclerosis	0.00207	0.0217	CbGeAlD
Estramustine—Hypernatraemia—Prednisolone—multiple sclerosis	0.00203	0.0108	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.00197	0.0278	CbGpPWpGaD
Estramustine—Depression—Fingolimod—multiple sclerosis	0.00194	0.0104	CcSEcCtD
Estramustine—Embolism venous—Triamcinolone—multiple sclerosis	0.00194	0.0104	CcSEcCtD
Estramustine—Embolism venous—Methylprednisolone—multiple sclerosis	0.00194	0.0104	CcSEcCtD
Estramustine—Hypernatraemia—Triamcinolone—multiple sclerosis	0.00186	0.00997	CcSEcCtD
Estramustine—ESR1—brainstem—multiple sclerosis	0.00186	0.0195	CbGeAlD
Estramustine—Hypernatraemia—Methylprednisolone—multiple sclerosis	0.00186	0.00995	CcSEcCtD
Estramustine—Embolism venous—Dexamethasone—multiple sclerosis	0.00176	0.00943	CcSEcCtD
Estramustine—Embolism venous—Betamethasone—multiple sclerosis	0.00176	0.00943	CcSEcCtD
Estramustine—Hypernatraemia—Dexamethasone—multiple sclerosis	0.00169	0.00905	CcSEcCtD
Estramustine—Hypernatraemia—Betamethasone—multiple sclerosis	0.00169	0.00905	CcSEcCtD
Estramustine—MAP2—brain—multiple sclerosis	0.00168	0.0176	CbGeAlD
Estramustine—Embolism—Prednisolone—multiple sclerosis	0.00166	0.00888	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.00161	0.0227	CbGpPWpGaD
Estramustine—ESR2—Ovarian Infertility Genes—PGR—multiple sclerosis	0.0016	0.0225	CbGpPWpGaD
Estramustine—Alopecia—Fingolimod—multiple sclerosis	0.00155	0.00828	CcSEcCtD
Estramustine—Embolism venous—Prednisone—multiple sclerosis	0.00153	0.00821	CcSEcCtD
Estramustine—Embolism—Triamcinolone—multiple sclerosis	0.00153	0.00817	CcSEcCtD
Estramustine—Embolism—Methylprednisolone—multiple sclerosis	0.00152	0.00815	CcSEcCtD
Estramustine—Hypernatraemia—Prednisone—multiple sclerosis	0.00147	0.00788	CcSEcCtD
Estramustine—Lethargy—Cladribine—multiple sclerosis	0.00146	0.00783	CcSEcCtD
Estramustine—Cerebrovascular accident—Cladribine—multiple sclerosis	0.00146	0.00783	CcSEcCtD
Estramustine—ESR2—nervous system—multiple sclerosis	0.00142	0.0149	CbGeAlD
Estramustine—Hypercalcaemia—Methylprednisolone—multiple sclerosis	0.00141	0.00753	CcSEcCtD
Estramustine—Raised liver function tests—Methotrexate—multiple sclerosis	0.0014	0.0075	CcSEcCtD
Estramustine—ESR2—Nuclear Receptors—PGR—multiple sclerosis	0.00139	0.0197	CbGpPWpGaD
Estramustine—Embolism—Betamethasone—multiple sclerosis	0.00138	0.00741	CcSEcCtD
Estramustine—Embolism—Dexamethasone—multiple sclerosis	0.00138	0.00741	CcSEcCtD
Estramustine—ESR2—central nervous system—multiple sclerosis	0.00137	0.0144	CbGeAlD
Estramustine—Leukopenia—Fingolimod—multiple sclerosis	0.00136	0.0073	CcSEcCtD
Estramustine—ESR2—cerebellum—multiple sclerosis	0.00134	0.014	CbGeAlD
Estramustine—MAP2—MAPK Cascade—MAPK1—multiple sclerosis	0.00122	0.0172	CbGpPWpGaD
Estramustine—Embolism—Prednisone—multiple sclerosis	0.00121	0.00646	CcSEcCtD
Estramustine—Abdominal discomfort—Cladribine—multiple sclerosis	0.00119	0.00636	CcSEcCtD
Estramustine—Pancytopenia—Cladribine—multiple sclerosis	0.00118	0.0063	CcSEcCtD
Estramustine—ESR2—Ovarian Infertility Genes—VDR—multiple sclerosis	0.00112	0.0158	CbGpPWpGaD
Estramustine—Dyspnoea—Fingolimod—multiple sclerosis	0.00111	0.00593	CcSEcCtD
Estramustine—ESR2—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.0011	0.0155	CbGpPWpGaD
Estramustine—ESR2—brain—multiple sclerosis	0.00109	0.0114	CbGeAlD
Estramustine—ESR1—ATF-2 transcription factor network—IL23A—multiple sclerosis	0.00106	0.0149	CbGpPWpGaD
Estramustine—Cardiac failure congestive—Mitoxantrone—multiple sclerosis	0.00104	0.00556	CcSEcCtD
Estramustine—Embolism—Methotrexate—multiple sclerosis	0.00101	0.0054	CcSEcCtD
Estramustine—ESR1—nervous system—multiple sclerosis	0.000975	0.0102	CbGeAlD
Estramustine—ESR2—Nuclear Receptors—VDR—multiple sclerosis	0.000974	0.0137	CbGpPWpGaD
Estramustine—Abdominal discomfort—Azathioprine—multiple sclerosis	0.000966	0.00517	CcSEcCtD
Estramustine—Pancytopenia—Azathioprine—multiple sclerosis	0.000957	0.00512	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Mitoxantrone—multiple sclerosis	0.000942	0.00505	CcSEcCtD
Estramustine—ESR1—central nervous system—multiple sclerosis	0.000939	0.00984	CbGeAlD
Estramustine—Skin exfoliation—Triamcinolone—multiple sclerosis	0.000935	0.00501	CcSEcCtD
Estramustine—Skin exfoliation—Methylprednisolone—multiple sclerosis	0.000933	0.005	CcSEcCtD
Estramustine—ESR2—Validated nuclear estrogen receptor alpha network—PGR—multiple sclerosis	0.000918	0.013	CbGpPWpGaD
Estramustine—ESR1—cerebellum—multiple sclerosis	0.000917	0.00962	CbGeAlD
Estramustine—MAP2—LKB1 signaling events—MYC—multiple sclerosis	0.000909	0.0128	CbGpPWpGaD
Estramustine—Thrombophlebitis—Prednisolone—multiple sclerosis	0.000893	0.00478	CcSEcCtD
Estramustine—Pruritus—Fingolimod—multiple sclerosis	0.000879	0.00471	CcSEcCtD
Estramustine—Alopecia—Cladribine—multiple sclerosis	0.000876	0.00469	CcSEcCtD
Estramustine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000868	0.0122	CbGpPWpGaD
Estramustine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000868	0.0122	CbGpPWpGaD
Estramustine—Cardiac failure congestive—Prednisolone—multiple sclerosis	0.000853	0.00456	CcSEcCtD
Estramustine—Flatulence—Cladribine—multiple sclerosis	0.000851	0.00456	CcSEcCtD
Estramustine—Diarrhoea—Fingolimod—multiple sclerosis	0.000851	0.00455	CcSEcCtD
Estramustine—Skin exfoliation—Betamethasone—multiple sclerosis	0.000848	0.00454	CcSEcCtD
Estramustine—Skin exfoliation—Dexamethasone—multiple sclerosis	0.000848	0.00454	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000831	0.0117	CbGpPWpGaD
Estramustine—Thrombophlebitis—Triamcinolone—multiple sclerosis	0.000821	0.0044	CcSEcCtD
Estramustine—Thrombophlebitis—Methylprednisolone—multiple sclerosis	0.000819	0.00439	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000818	0.0115	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000794	0.0112	CbGpPWpGaD
Estramustine—Cardiac failure congestive—Triamcinolone—multiple sclerosis	0.000784	0.0042	CcSEcCtD
Estramustine—Cardiac failure congestive—Methylprednisolone—multiple sclerosis	0.000782	0.00419	CcSEcCtD
Estramustine—Headache—Fingolimod—multiple sclerosis	0.000779	0.00417	CcSEcCtD
Estramustine—Pancytopenia—Mitoxantrone—multiple sclerosis	0.000774	0.00414	CcSEcCtD
Estramustine—ESR2—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.000769	0.0109	CbGpPWpGaD
Estramustine—Affect lability—Prednisolone—multiple sclerosis	0.000761	0.00407	CcSEcCtD
Estramustine—Erectile dysfunction—Mitoxantrone—multiple sclerosis	0.00075	0.00402	CcSEcCtD
Estramustine—Thrombophlebitis—Betamethasone—multiple sclerosis	0.000745	0.00399	CcSEcCtD
Estramustine—Thrombophlebitis—Dexamethasone—multiple sclerosis	0.000745	0.00399	CcSEcCtD
Estramustine—ESR1—brain—multiple sclerosis	0.000745	0.00781	CbGeAlD
Estramustine—Skin exfoliation—Prednisone—multiple sclerosis	0.000739	0.00396	CcSEcCtD
Estramustine—Cardiac arrest—Prednisolone—multiple sclerosis	0.000735	0.00394	CcSEcCtD
Estramustine—Chest pain—Cladribine—multiple sclerosis	0.000735	0.00394	CcSEcCtD
Estramustine—Anxiety—Cladribine—multiple sclerosis	0.000733	0.00392	CcSEcCtD
Estramustine—Mood swings—Prednisolone—multiple sclerosis	0.000732	0.00392	CcSEcCtD
Estramustine—Acute coronary syndrome—Mitoxantrone—multiple sclerosis	0.000716	0.00383	CcSEcCtD
Estramustine—Eye pain—Betamethasone—multiple sclerosis	0.000715	0.00383	CcSEcCtD
Estramustine—Eye pain—Dexamethasone—multiple sclerosis	0.000715	0.00383	CcSEcCtD
Estramustine—Alopecia—Azathioprine—multiple sclerosis	0.000713	0.00382	CcSEcCtD
Estramustine—Myocardial infarction—Mitoxantrone—multiple sclerosis	0.000712	0.00381	CcSEcCtD
Estramustine—Cardiac failure congestive—Betamethasone—multiple sclerosis	0.000711	0.00381	CcSEcCtD
Estramustine—Cardiac failure congestive—Dexamethasone—multiple sclerosis	0.000711	0.00381	CcSEcCtD
Estramustine—ABCB1—retina—multiple sclerosis	0.000709	0.00743	CbGeAlD
Estramustine—Dry skin—Prednisolone—multiple sclerosis	0.000709	0.00379	CcSEcCtD
Estramustine—Oedema—Cladribine—multiple sclerosis	0.000705	0.00377	CcSEcCtD
Estramustine—ESR1—Nuclear Receptors—PGR—multiple sclerosis	0.000703	0.00991	CbGpPWpGaD
Estramustine—Affect lability—Triamcinolone—multiple sclerosis	0.0007	0.00375	CcSEcCtD
Estramustine—Affect lability—Methylprednisolone—multiple sclerosis	0.000698	0.00374	CcSEcCtD
Estramustine—Thrombocytopenia—Cladribine—multiple sclerosis	0.00069	0.00369	CcSEcCtD
Estramustine—ESR1—Nuclear signaling by ERBB4—PGR—multiple sclerosis	0.000688	0.00971	CbGpPWpGaD
Estramustine—Cardiac arrest—Triamcinolone—multiple sclerosis	0.000676	0.00362	CcSEcCtD
Estramustine—Cardiac arrest—Methylprednisolone—multiple sclerosis	0.000675	0.00361	CcSEcCtD
Estramustine—Mood swings—Triamcinolone—multiple sclerosis	0.000674	0.00361	CcSEcCtD
Estramustine—Mood swings—Methylprednisolone—multiple sclerosis	0.000672	0.0036	CcSEcCtD
Estramustine—Anorexia—Cladribine—multiple sclerosis	0.000672	0.0036	CcSEcCtD
Estramustine—Lethargy—Betamethasone—multiple sclerosis	0.000658	0.00352	CcSEcCtD
Estramustine—Lethargy—Dexamethasone—multiple sclerosis	0.000658	0.00352	CcSEcCtD
Estramustine—Thrombophlebitis—Prednisone—multiple sclerosis	0.000649	0.00348	CcSEcCtD
Estramustine—Insomnia—Cladribine—multiple sclerosis	0.000637	0.00341	CcSEcCtD
Estramustine—Affect lability—Dexamethasone—multiple sclerosis	0.000635	0.0034	CcSEcCtD
Estramustine—Affect lability—Betamethasone—multiple sclerosis	0.000635	0.0034	CcSEcCtD
Estramustine—ESR2—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.00063	0.00889	CbGpPWpGaD
Estramustine—Leukopenia—Azathioprine—multiple sclerosis	0.000628	0.00336	CcSEcCtD
Estramustine—Dyspnoea—Cladribine—multiple sclerosis	0.000628	0.00336	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.00062	0.00874	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.00062	0.00874	CbGpPWpGaD
Estramustine—Cardiac failure congestive—Prednisone—multiple sclerosis	0.000619	0.00332	CcSEcCtD
Estramustine—Skin exfoliation—Methotrexate—multiple sclerosis	0.000618	0.00331	CcSEcCtD
Estramustine—Cardiac arrest—Betamethasone—multiple sclerosis	0.000613	0.00328	CcSEcCtD
Estramustine—Cardiac arrest—Dexamethasone—multiple sclerosis	0.000613	0.00328	CcSEcCtD
Estramustine—Decreased appetite—Cladribine—multiple sclerosis	0.000613	0.00328	CcSEcCtD
Estramustine—Mood swings—Dexamethasone—multiple sclerosis	0.000611	0.00327	CcSEcCtD
Estramustine—Mood swings—Betamethasone—multiple sclerosis	0.000611	0.00327	CcSEcCtD
Estramustine—ESR1—ATF-2 transcription factor network—SELE—multiple sclerosis	0.000606	0.00855	CbGpPWpGaD
Estramustine—Dry skin—Betamethasone—multiple sclerosis	0.000591	0.00317	CcSEcCtD
Estramustine—Dry skin—Dexamethasone—multiple sclerosis	0.000591	0.00317	CcSEcCtD
Estramustine—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.000587	0.00314	CcSEcCtD
Estramustine—Myocardial infarction—Prednisolone—multiple sclerosis	0.000584	0.00313	CcSEcCtD
Estramustine—Gynaecomastia—Methotrexate—multiple sclerosis	0.000579	0.0031	CcSEcCtD
Estramustine—Alopecia—Mitoxantrone—multiple sclerosis	0.000576	0.00308	CcSEcCtD
Estramustine—Lethargy—Prednisone—multiple sclerosis	0.000573	0.00307	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Prednisone—multiple sclerosis	0.000562	0.00301	CcSEcCtD
Estramustine—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000561	0.003	CcSEcCtD
Estramustine—ESR1—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.000555	0.00783	CbGpPWpGaD
Estramustine—Affect lability—Prednisone—multiple sclerosis	0.000553	0.00296	CcSEcCtD
Estramustine—CYP3A4—nervous system—multiple sclerosis	0.000544	0.0057	CbGeAlD
Estramustine—Thrombophlebitis—Methotrexate—multiple sclerosis	0.000542	0.0029	CcSEcCtD
Estramustine—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.00054	0.00289	CcSEcCtD
Estramustine—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.000539	0.00289	CcSEcCtD
Estramustine—Myocardial infarction—Triamcinolone—multiple sclerosis	0.000537	0.00288	CcSEcCtD
Estramustine—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.000536	0.00287	CcSEcCtD
Estramustine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000535	0.00754	CbGpPWpGaD
Estramustine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000535	0.00754	CbGpPWpGaD
Estramustine—Cardiac arrest—Prednisone—multiple sclerosis	0.000534	0.00286	CcSEcCtD
Estramustine—Mood swings—Prednisone—multiple sclerosis	0.000532	0.00285	CcSEcCtD
Estramustine—CYP3A4—central nervous system—multiple sclerosis	0.000524	0.00549	CbGeAlD
Estramustine—Dry skin—Prednisone—multiple sclerosis	0.000515	0.00276	CcSEcCtD
Estramustine—ABCB1—medulla oblongata—multiple sclerosis	0.000512	0.00537	CbGeAlD
Estramustine—Leukopenia—Mitoxantrone—multiple sclerosis	0.000508	0.00272	CcSEcCtD
Estramustine—Pruritus—Cladribine—multiple sclerosis	0.000499	0.00267	CcSEcCtD
Estramustine—ESR1—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000495	0.00699	CbGpPWpGaD
Estramustine—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000494	0.00697	CbGpPWpGaD
Estramustine—ESR1—Nuclear Receptors—VDR—multiple sclerosis	0.000491	0.00692	CbGpPWpGaD
Estramustine—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.00049	0.00262	CcSEcCtD
Estramustine—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.00049	0.00262	CcSEcCtD
Estramustine—Myocardial infarction—Dexamethasone—multiple sclerosis	0.000487	0.00261	CcSEcCtD
Estramustine—Myocardial infarction—Betamethasone—multiple sclerosis	0.000487	0.00261	CcSEcCtD
Estramustine—Chest pain—Mitoxantrone—multiple sclerosis	0.000483	0.00259	CcSEcCtD
Estramustine—Diarrhoea—Cladribine—multiple sclerosis	0.000482	0.00258	CcSEcCtD
Estramustine—Anxiety—Mitoxantrone—multiple sclerosis	0.000481	0.00258	CcSEcCtD
Estramustine—Lethargy—Methotrexate—multiple sclerosis	0.000479	0.00257	CcSEcCtD
Estramustine—Cerebrovascular accident—Methotrexate—multiple sclerosis	0.000479	0.00257	CcSEcCtD
Estramustine—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000473	0.00668	CbGpPWpGaD
Estramustine—ABCB1—midbrain—multiple sclerosis	0.000468	0.00491	CbGeAlD
Estramustine—Oedema—Mitoxantrone—multiple sclerosis	0.000463	0.00248	CcSEcCtD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—PGR—multiple sclerosis	0.000463	0.00653	CbGpPWpGaD
Estramustine—ABCB1—spinal cord—multiple sclerosis	0.000457	0.00479	CbGeAlD
Estramustine—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000453	0.00243	CcSEcCtD
Estramustine—Vomiting—Cladribine—multiple sclerosis	0.000448	0.0024	CcSEcCtD
Estramustine—Erectile dysfunction—Prednisone—multiple sclerosis	0.000447	0.00239	CcSEcCtD
Estramustine—Mood swings—Methotrexate—multiple sclerosis	0.000445	0.00238	CcSEcCtD
Estramustine—Rash—Cladribine—multiple sclerosis	0.000444	0.00238	CcSEcCtD
Estramustine—Dermatitis—Cladribine—multiple sclerosis	0.000444	0.00238	CcSEcCtD
Estramustine—Anorexia—Mitoxantrone—multiple sclerosis	0.000442	0.00236	CcSEcCtD
Estramustine—Headache—Cladribine—multiple sclerosis	0.000441	0.00236	CcSEcCtD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—MMP9—multiple sclerosis	0.000441	0.00622	CbGpPWpGaD
Estramustine—Liver function test abnormal—Methotrexate—multiple sclerosis	0.000433	0.00232	CcSEcCtD
Estramustine—Depression—Prednisone—multiple sclerosis	0.000432	0.00231	CcSEcCtD
Estramustine—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000427	0.00229	CcSEcCtD
Estramustine—Myocardial infarction—Prednisone—multiple sclerosis	0.000424	0.00227	CcSEcCtD
Estramustine—ESR1—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	0.000423	0.00597	CbGpPWpGaD
Estramustine—Nausea—Cladribine—multiple sclerosis	0.000419	0.00224	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000416	0.00587	CbGpPWpGaD
Estramustine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000413	0.00221	CcSEcCtD
Estramustine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000403	0.00216	CcSEcCtD
Estramustine—Alopecia—Betamethasone—multiple sclerosis	0.000394	0.00211	CcSEcCtD
Estramustine—Alopecia—Dexamethasone—multiple sclerosis	0.000394	0.00211	CcSEcCtD
Estramustine—Diarrhoea—Azathioprine—multiple sclerosis	0.000392	0.0021	CcSEcCtD
Estramustine—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000389	0.00208	CcSEcCtD
Estramustine—ESR1—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.000388	0.00547	CbGpPWpGaD
Estramustine—Pancytopenia—Methotrexate—multiple sclerosis	0.000385	0.00206	CcSEcCtD
Estramustine—ABCB1—nervous system—multiple sclerosis	0.000385	0.00404	CbGeAlD
Estramustine—Oedema—Prednisolone—multiple sclerosis	0.00038	0.00203	CcSEcCtD
Estramustine—ABCB1—Allograft Rejection—C4A—multiple sclerosis	0.000376	0.0053	CbGpPWpGaD
Estramustine—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000374	0.002	CcSEcCtD
Estramustine—ABCB1—central nervous system—multiple sclerosis	0.000371	0.00389	CbGeAlD
Estramustine—Vomiting—Azathioprine—multiple sclerosis	0.000364	0.00195	CcSEcCtD
Estramustine—Anxiety—Methylprednisolone—multiple sclerosis	0.000362	0.00194	CcSEcCtD
Estramustine—ABCB1—cerebellum—multiple sclerosis	0.000362	0.0038	CbGeAlD
Estramustine—Rash—Azathioprine—multiple sclerosis	0.000361	0.00193	CcSEcCtD
Estramustine—Dermatitis—Azathioprine—multiple sclerosis	0.000361	0.00193	CcSEcCtD
Estramustine—Depression—Methotrexate—multiple sclerosis	0.000361	0.00193	CcSEcCtD
Estramustine—Flushing—Prednisone—multiple sclerosis	0.000361	0.00193	CcSEcCtD
Estramustine—Headache—Azathioprine—multiple sclerosis	0.000359	0.00192	CcSEcCtD
Estramustine—Oedema—Triamcinolone—multiple sclerosis	0.000349	0.00187	CcSEcCtD
Estramustine—Insomnia—Prednisolone—multiple sclerosis	0.000344	0.00184	CcSEcCtD
Estramustine—Alopecia—Prednisone—multiple sclerosis	0.000343	0.00184	CcSEcCtD
Estramustine—Nausea—Azathioprine—multiple sclerosis	0.00034	0.00182	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.00034	0.00479	CbGpPWpGaD
Estramustine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000339	0.00479	CbGpPWpGaD
Estramustine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000339	0.00479	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	0.000338	0.00476	CbGpPWpGaD
Estramustine—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000335	0.00472	CbGpPWpGaD
Estramustine—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000335	0.00472	CbGpPWpGaD
Estramustine—Anxiety—Betamethasone—multiple sclerosis	0.00033	0.00176	CcSEcCtD
Estramustine—Anxiety—Dexamethasone—multiple sclerosis	0.00033	0.00176	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000321	0.00452	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.000318	0.00448	CbGpPWpGaD
Estramustine—Oedema—Betamethasone—multiple sclerosis	0.000317	0.0017	CcSEcCtD
Estramustine—Oedema—Dexamethasone—multiple sclerosis	0.000317	0.0017	CcSEcCtD
Estramustine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000317	0.0017	CcSEcCtD
Estramustine—Insomnia—Triamcinolone—multiple sclerosis	0.000316	0.00169	CcSEcCtD
Estramustine—Insomnia—Methylprednisolone—multiple sclerosis	0.000315	0.00169	CcSEcCtD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000313	0.00441	CbGpPWpGaD
Estramustine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000312	0.00167	CcSEcCtD
Estramustine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00031	0.00166	CcSEcCtD
Estramustine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00031	0.00166	CcSEcCtD
Estramustine—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	0.000306	0.00432	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	0.000306	0.00432	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000306	0.00432	CbGpPWpGaD
Estramustine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000305	0.0043	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—ZNF746—multiple sclerosis	0.000304	0.00428	CbGpPWpGaD
Estramustine—Tinnitus—Methotrexate—multiple sclerosis	0.000303	0.00162	CcSEcCtD
Estramustine—Anorexia—Dexamethasone—multiple sclerosis	0.000302	0.00162	CcSEcCtD
Estramustine—Anorexia—Betamethasone—multiple sclerosis	0.000302	0.00162	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000302	0.00426	CbGpPWpGaD
Estramustine—Vomiting—Mitoxantrone—multiple sclerosis	0.000294	0.00158	CcSEcCtD
Estramustine—ABCB1—brain—multiple sclerosis	0.000294	0.00309	CbGeAlD
Estramustine—ESR1—AP-1 transcription factor network—IL10—multiple sclerosis	0.000293	0.00413	CbGpPWpGaD
Estramustine—Rash—Mitoxantrone—multiple sclerosis	0.000292	0.00156	CcSEcCtD
Estramustine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000292	0.00156	CcSEcCtD
Estramustine—Headache—Mitoxantrone—multiple sclerosis	0.00029	0.00155	CcSEcCtD
Estramustine—Anxiety—Prednisone—multiple sclerosis	0.000287	0.00154	CcSEcCtD
Estramustine—Alopecia—Methotrexate—multiple sclerosis	0.000287	0.00154	CcSEcCtD
Estramustine—Insomnia—Dexamethasone—multiple sclerosis	0.000287	0.00154	CcSEcCtD
Estramustine—Insomnia—Betamethasone—multiple sclerosis	0.000287	0.00154	CcSEcCtD
Estramustine—ESR1—Estrogen signaling pathway—MAPK1—multiple sclerosis	0.000285	0.00402	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—IL4—multiple sclerosis	0.000285	0.00402	CbGpPWpGaD
Estramustine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000284	0.004	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.000279	0.00393	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—PTBP1—multiple sclerosis	0.000278	0.00392	CbGpPWpGaD
Estramustine—Oedema—Prednisone—multiple sclerosis	0.000276	0.00148	CcSEcCtD
Estramustine—Decreased appetite—Betamethasone—multiple sclerosis	0.000276	0.00148	CcSEcCtD
Estramustine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000276	0.00148	CcSEcCtD
Estramustine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000275	0.00388	CbGpPWpGaD
Estramustine—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000275	0.00388	CbGpPWpGaD
Estramustine—Nausea—Mitoxantrone—multiple sclerosis	0.000275	0.00147	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000273	0.00384	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	0.000268	0.00378	CbGpPWpGaD
Estramustine—Anorexia—Prednisone—multiple sclerosis	0.000263	0.00141	CcSEcCtD
Estramustine—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.000263	0.00371	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	0.000261	0.00368	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—HLA-A—multiple sclerosis	0.000258	0.00364	CbGpPWpGaD
Estramustine—ESR2—Validated nuclear estrogen receptor alpha network—MYC—multiple sclerosis	0.000255	0.0036	CbGpPWpGaD
Estramustine—Leukopenia—Methotrexate—multiple sclerosis	0.000253	0.00136	CcSEcCtD
Estramustine—Insomnia—Prednisone—multiple sclerosis	0.00025	0.00134	CcSEcCtD
Estramustine—Pruritus—Triamcinolone—multiple sclerosis	0.000247	0.00132	CcSEcCtD
Estramustine—Pruritus—Methylprednisolone—multiple sclerosis	0.000247	0.00132	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000244	0.00344	CbGpPWpGaD
Estramustine—Chest pain—Methotrexate—multiple sclerosis	0.000241	0.00129	CcSEcCtD
Estramustine—Decreased appetite—Prednisone—multiple sclerosis	0.00024	0.00129	CcSEcCtD
Estramustine—Rash—Prednisolone—multiple sclerosis	0.00024	0.00128	CcSEcCtD
Estramustine—Dermatitis—Prednisolone—multiple sclerosis	0.000239	0.00128	CcSEcCtD
Estramustine—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.000239	0.00337	CbGpPWpGaD
Estramustine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000239	0.00128	CcSEcCtD
Estramustine—Headache—Prednisolone—multiple sclerosis	0.000238	0.00127	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000233	0.00329	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—PGR—multiple sclerosis	0.000232	0.00327	CbGpPWpGaD
Estramustine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000226	0.00121	CcSEcCtD
Estramustine—Nausea—Prednisolone—multiple sclerosis	0.000226	0.00121	CcSEcCtD
Estramustine—ESR1—Signaling by ERBB4—CD28—multiple sclerosis	0.000225	0.00318	CbGpPWpGaD
Estramustine—Pruritus—Dexamethasone—multiple sclerosis	0.000224	0.0012	CcSEcCtD
Estramustine—Pruritus—Betamethasone—multiple sclerosis	0.000224	0.0012	CcSEcCtD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—MMP9—multiple sclerosis	0.000222	0.00313	CbGpPWpGaD
Estramustine—Vomiting—Triamcinolone—multiple sclerosis	0.000222	0.00119	CcSEcCtD
Estramustine—Vomiting—Methylprednisolone—multiple sclerosis	0.000222	0.00119	CcSEcCtD
Estramustine—Rash—Triamcinolone—multiple sclerosis	0.00022	0.00118	CcSEcCtD
Estramustine—Dermatitis—Triamcinolone—multiple sclerosis	0.00022	0.00118	CcSEcCtD
Estramustine—Anorexia—Methotrexate—multiple sclerosis	0.00022	0.00118	CcSEcCtD
Estramustine—Rash—Methylprednisolone—multiple sclerosis	0.00022	0.00118	CcSEcCtD
Estramustine—Dermatitis—Methylprednisolone—multiple sclerosis	0.00022	0.00118	CcSEcCtD
Estramustine—Headache—Triamcinolone—multiple sclerosis	0.000219	0.00117	CcSEcCtD
Estramustine—Headache—Methylprednisolone—multiple sclerosis	0.000218	0.00117	CcSEcCtD
Estramustine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000217	0.00116	CcSEcCtD
Estramustine—Diarrhoea—Betamethasone—multiple sclerosis	0.000217	0.00116	CcSEcCtD
Estramustine—ESR2—Gene Expression—HNRNPA1—multiple sclerosis	0.00021	0.00297	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—U2AF2—multiple sclerosis	0.00021	0.00297	CbGpPWpGaD
Estramustine—Insomnia—Methotrexate—multiple sclerosis	0.000209	0.00112	CcSEcCtD
Estramustine—Nausea—Triamcinolone—multiple sclerosis	0.000208	0.00111	CcSEcCtD
Estramustine—Nausea—Methylprednisolone—multiple sclerosis	0.000207	0.00111	CcSEcCtD
Estramustine—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000207	0.00292	CbGpPWpGaD
Estramustine—Dyspnoea—Methotrexate—multiple sclerosis	0.000206	0.0011	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—CCL2—multiple sclerosis	0.000203	0.00286	CbGpPWpGaD
Estramustine—Vomiting—Dexamethasone—multiple sclerosis	0.000202	0.00108	CcSEcCtD
Estramustine—Vomiting—Betamethasone—multiple sclerosis	0.000202	0.00108	CcSEcCtD
Estramustine—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000201	0.00284	CbGpPWpGaD
Estramustine—Decreased appetite—Methotrexate—multiple sclerosis	0.000201	0.00107	CcSEcCtD
Estramustine—Rash—Betamethasone—multiple sclerosis	0.0002	0.00107	CcSEcCtD
Estramustine—Rash—Dexamethasone—multiple sclerosis	0.0002	0.00107	CcSEcCtD
Estramustine—Dermatitis—Dexamethasone—multiple sclerosis	0.0002	0.00107	CcSEcCtD
Estramustine—Dermatitis—Betamethasone—multiple sclerosis	0.0002	0.00107	CcSEcCtD
Estramustine—Headache—Betamethasone—multiple sclerosis	0.000199	0.00106	CcSEcCtD
Estramustine—Headache—Dexamethasone—multiple sclerosis	0.000199	0.00106	CcSEcCtD
Estramustine—ESR1—ATF-2 transcription factor network—IFNG—multiple sclerosis	0.000198	0.00279	CbGpPWpGaD
Estramustine—Pruritus—Prednisone—multiple sclerosis	0.000195	0.00105	CcSEcCtD
Estramustine—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.000192	0.00271	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000191	0.00269	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—PGR—multiple sclerosis	0.00019	0.00268	CbGpPWpGaD
Estramustine—Diarrhoea—Prednisone—multiple sclerosis	0.000189	0.00101	CcSEcCtD
Estramustine—Nausea—Dexamethasone—multiple sclerosis	0.000188	0.00101	CcSEcCtD
Estramustine—Nausea—Betamethasone—multiple sclerosis	0.000188	0.00101	CcSEcCtD
Estramustine—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.000184	0.00259	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000181	0.00255	CbGpPWpGaD
Estramustine—ESR1—FOXM1 transcription factor network—MYC—multiple sclerosis	0.00018	0.00254	CbGpPWpGaD
Estramustine—ESR1—LKB1 signaling events—MYC—multiple sclerosis	0.000177	0.00249	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—IFNG—multiple sclerosis	0.000176	0.00249	CbGpPWpGaD
Estramustine—Vomiting—Prednisone—multiple sclerosis	0.000176	0.00094	CcSEcCtD
Estramustine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000175	0.00247	CbGpPWpGaD
Estramustine—Rash—Prednisone—multiple sclerosis	0.000174	0.000932	CcSEcCtD
Estramustine—Dermatitis—Prednisone—multiple sclerosis	0.000174	0.000931	CcSEcCtD
Estramustine—Headache—Prednisone—multiple sclerosis	0.000173	0.000926	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—IFNG—multiple sclerosis	0.000172	0.00243	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000171	0.00241	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.000167	0.00236	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—ZFP36L1—multiple sclerosis	0.000166	0.00235	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000165	0.00233	CbGpPWpGaD
Estramustine—Nausea—Prednisone—multiple sclerosis	0.000164	0.000878	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	0.000164	0.00231	CbGpPWpGaD
Estramustine—Pruritus—Methotrexate—multiple sclerosis	0.000163	0.000874	CcSEcCtD
Estramustine—ESR1—Signaling by ERBB4—CD86—multiple sclerosis	0.000161	0.00227	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000161	0.00226	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.000159	0.00225	CbGpPWpGaD
Estramustine—Diarrhoea—Methotrexate—multiple sclerosis	0.000158	0.000845	CcSEcCtD
Estramustine—ESR1—Regulation of Telomerase—IL2—multiple sclerosis	0.000157	0.00221	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	0.000156	0.0022	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—IL2—multiple sclerosis	0.000153	0.00216	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—ZNF746—multiple sclerosis	0.000153	0.00216	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.000149	0.0021	CbGpPWpGaD
Estramustine—Vomiting—Methotrexate—multiple sclerosis	0.000147	0.000786	CcSEcCtD
Estramustine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000146	0.00206	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000146	0.00206	CbGpPWpGaD
Estramustine—Rash—Methotrexate—multiple sclerosis	0.000146	0.000779	CcSEcCtD
Estramustine—ESR1—Leptin signaling pathway—IL1B—multiple sclerosis	0.000145	0.00205	CbGpPWpGaD
Estramustine—Dermatitis—Methotrexate—multiple sclerosis	0.000145	0.000778	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—MMP9—multiple sclerosis	0.000145	0.00204	CbGpPWpGaD
Estramustine—Headache—Methotrexate—multiple sclerosis	0.000145	0.000774	CcSEcCtD
Estramustine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000144	0.00203	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000144	0.00203	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—CD86—multiple sclerosis	0.000143	0.00202	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	0.000141	0.00198	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—IL10—multiple sclerosis	0.000141	0.00198	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—PTBP1—multiple sclerosis	0.00014	0.00197	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000137	0.00194	CbGpPWpGaD
Estramustine—Nausea—Methotrexate—multiple sclerosis	0.000137	0.000734	CcSEcCtD
Estramustine—ABCB1—Allograft Rejection—IL4—multiple sclerosis	0.000137	0.00193	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—MAPK1—multiple sclerosis	0.000134	0.00189	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	0.000134	0.00189	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—VDR—multiple sclerosis	0.000133	0.00187	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—PABPC1—multiple sclerosis	0.000129	0.00182	CbGpPWpGaD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—MYC—multiple sclerosis	0.000129	0.00181	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—FAS—multiple sclerosis	0.000126	0.00178	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	0.000125	0.00177	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	0.000124	0.00175	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—MYC—multiple sclerosis	0.000123	0.00173	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—TGFB1—multiple sclerosis	0.000122	0.00172	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—STAT3—multiple sclerosis	0.000122	0.00172	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—MAPK1—multiple sclerosis	0.00012	0.00169	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—MYC—multiple sclerosis	0.00012	0.00169	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—TGFB1—multiple sclerosis	0.000119	0.00168	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000118	0.00166	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—CD80—multiple sclerosis	0.000117	0.00165	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000116	0.00164	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—RPL5—multiple sclerosis	0.000116	0.00164	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	0.000113	0.0016	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—MAPK1—multiple sclerosis	0.000111	0.00156	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	0.000107	0.0015	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	0.000106	0.0015	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—HNRNPA1—multiple sclerosis	0.000106	0.0015	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—U2AF2—multiple sclerosis	0.000106	0.0015	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	0.000106	0.0015	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—CD80—multiple sclerosis	0.000105	0.00148	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	0.000104	0.00147	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—IL6—multiple sclerosis	0.000103	0.00145	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	9.91e-05	0.0014	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—TYK2—multiple sclerosis	9.89e-05	0.0014	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—PGR—multiple sclerosis	9.59e-05	0.00135	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	9.4e-05	0.00133	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	9.32e-05	0.00131	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—PGR—multiple sclerosis	9.16e-05	0.00129	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	9.06e-05	0.00128	CbGpPWpGaD
Estramustine—Estropipate—ALB—multiple sclerosis	9.04e-05	0.404	CrCbGaD
Estramustine—ESR1—AP-1 transcription factor network—IL6—multiple sclerosis	9e-05	0.00127	CbGpPWpGaD
Estramustine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	8.42e-05	0.00119	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—ZFP36L1—multiple sclerosis	8.39e-05	0.00118	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	8.27e-05	0.00117	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—LINGO1—multiple sclerosis	7.95e-05	0.00112	CbGpPWpGaD
Estramustine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.64e-05	0.00108	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	7.38e-05	0.00104	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—IL2—multiple sclerosis	7.35e-05	0.00104	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	7.27e-05	0.00103	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.06e-05	0.000996	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TAGAP—multiple sclerosis	6.9e-05	0.000973	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—VDR—multiple sclerosis	6.7e-05	0.000945	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—PABPC1—multiple sclerosis	6.5e-05	0.000917	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	6.47e-05	0.000913	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—VDR—multiple sclerosis	6.4e-05	0.000902	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	6.33e-05	0.000893	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—MAPK1—multiple sclerosis	6.3e-05	0.000888	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	6.22e-05	0.000878	CbGpPWpGaD
Estramustine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.19e-05	0.000873	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—S1PR1—multiple sclerosis	6.03e-05	0.00085	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—RPL5—multiple sclerosis	5.86e-05	0.000827	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—GPC5—multiple sclerosis	5.86e-05	0.000827	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—SRM—multiple sclerosis	5.76e-05	0.000812	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	5.73e-05	0.000809	CbGpPWpGaD
Estramustine—Estrone—ALB—multiple sclerosis	5.63e-05	0.252	CrCbGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.58e-05	0.000787	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	5.36e-05	0.000756	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—TNF—multiple sclerosis	5.36e-05	0.000755	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	5.35e-05	0.000754	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—MYC—multiple sclerosis	5.28e-05	0.000745	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	5.25e-05	0.00074	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—RGS1—multiple sclerosis	5.13e-05	0.000723	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	4.99e-05	0.000704	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.93e-05	0.000696	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—GPR65—multiple sclerosis	4.86e-05	0.000685	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—IL6—multiple sclerosis	4.84e-05	0.000682	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—PGR—multiple sclerosis	4.62e-05	0.000651	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CXCL13—multiple sclerosis	4.44e-05	0.000627	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CCR1—multiple sclerosis	4.44e-05	0.000627	CbGpPWpGaD
Estramustine—Estradiol—ALB—multiple sclerosis	4.27e-05	0.191	CrCbGaD
Estramustine—ABCB1—Metabolism—CYP27B1—multiple sclerosis	4.06e-05	0.000572	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP24A1—multiple sclerosis	4.06e-05	0.000572	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GPC5—multiple sclerosis	3.71e-05	0.000523	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—SRM—multiple sclerosis	3.55e-05	0.0005	CbGpPWpGaD
Estramustine—Testosterone—ALB—multiple sclerosis	3.42e-05	0.153	CrCbGaD
Estramustine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.29e-05	0.000464	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—VDR—multiple sclerosis	3.23e-05	0.000455	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CCL3—multiple sclerosis	3.17e-05	0.000447	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—RRM1—multiple sclerosis	3.07e-05	0.000434	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PTGER4—multiple sclerosis	3.05e-05	0.00043	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PGR—multiple sclerosis	3e-05	0.000423	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CXCR3—multiple sclerosis	2.94e-05	0.000415	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CD28—multiple sclerosis	2.92e-05	0.000411	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CCR2—multiple sclerosis	2.86e-05	0.000404	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.84e-05	0.0004	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.83e-05	0.000399	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.78e-05	0.000391	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—MYC—multiple sclerosis	2.66e-05	0.000376	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CNR1—multiple sclerosis	2.64e-05	0.000373	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.64e-05	0.000373	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—MYC—multiple sclerosis	2.54e-05	0.000359	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.5e-05	0.000353	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.5e-05	0.000353	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CXCL10—multiple sclerosis	2.38e-05	0.000336	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.29e-05	0.000322	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CD86—multiple sclerosis	2.08e-05	0.000293	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CCL5—multiple sclerosis	2.05e-05	0.000289	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SPP1—multiple sclerosis	1.9e-05	0.000268	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.89e-05	0.000267	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CCR5—multiple sclerosis	1.85e-05	0.00026	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IL2RA—multiple sclerosis	1.82e-05	0.000257	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.78e-05	0.000251	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—BCHE—multiple sclerosis	1.77e-05	0.000249	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—APOE—multiple sclerosis	1.68e-05	0.000237	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CD80—multiple sclerosis	1.52e-05	0.000214	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—POMC—multiple sclerosis	1.44e-05	0.000203	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CCL2—multiple sclerosis	1.41e-05	0.000199	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—MYC—multiple sclerosis	1.28e-05	0.000181	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TYK2—multiple sclerosis	1.28e-05	0.000181	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.09e-05	0.000153	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IL2—multiple sclerosis	1.07e-05	0.00015	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—APOE—multiple sclerosis	1.06e-05	0.00015	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MMP9—multiple sclerosis	1.01e-05	0.000142	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—POMC—multiple sclerosis	9.13e-06	0.000129	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—STAT3—multiple sclerosis	8.97e-06	0.000127	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MYC—multiple sclerosis	8.34e-06	0.000118	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ALB—multiple sclerosis	8.32e-06	0.000117	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TGFB1—multiple sclerosis	8.32e-06	0.000117	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MAPK1—multiple sclerosis	8.16e-06	0.000115	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—APOE—multiple sclerosis	6.55e-06	9.23e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IL6—multiple sclerosis	6.27e-06	8.84e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—POMC—multiple sclerosis	5.62e-06	7.93e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ALB—multiple sclerosis	5.13e-06	7.23e-05	CbGpPWpGaD
